These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29334162)

  • 1. Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.
    Al Mutairi N; Alrqobah D; Haji Hussain N
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29334162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of metabolic syndrome with pediatric psoriasis: a case-control study in Kabul, Afghanistan.
    Aalemi AK; Hamdard AG; Chen H
    Int J Dermatol; 2020 Apr; 59(4):451-456. PubMed ID: 32043572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
    Potenza MC; Peris K; Berardesca E; Bianchi L; Richetta A; Bernardini N; De Simone C; Teoli M; Zangrilli A; D'epiro S; Orsini D; Narcisi A; Chimenti S; Costanzo A
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29215183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome in patients with psoriasis.
    Zindancı I; Albayrak O; Kavala M; Kocaturk E; Can B; Sudogan S; Koç M
    ScientificWorldJournal; 2012; 2012():312463. PubMed ID: 22654590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and psoriasis: a study in 97 patients.
    Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in Montenegrin patients with psoriasis.
    Ražnatović-Đurović M; Janković J; Janković S
    Vojnosanit Pregl; 2016 Nov; 73(11):1016-21. PubMed ID: 29328640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey.
    Al-Thani MH; Al-Thani AA; Cheema S; Sheikh J; Mamtani R; Lowenfels AB; Al-Chetachi WF; Almalki BA; Hassan Khalifa SA; Haj Bakri AO; Maisonneuve P
    BMJ Open; 2016 Sep; 6(9):e009514. PubMed ID: 27601485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
    Inzinger M; Wippel-Slupetzky K; Weger W; Richter L; Mlynek A; Fleischander B; Scheurecker C; Sandor N; Mairhofer D; Sator PG; Moser-Oberthaler S; Häring N; Viznerova P; Painsi C; Tanew A; Ponholzer P; Tatarski R; Brenner W; Stingl G; Salmhofer W; Rappersberger K; Klein G; Saxinger W; Auböck J; Kölli C; Trautinger F; Steiner A; Ratzinger G; Strohal R; Riedl E; Lange-Asschenfeldt B; Pehamberger H; Volc-Platzer B; Selhofer S; Legat FJ; Müllegger R; Reider N; Schmuth M; Hintner H; Hofer A; Gruber-Wackernagel A; Aberer W; Quehenberger F; Wolf P
    Acta Derm Venereol; 2016 Feb; 96(2):207-12. PubMed ID: 26271044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.
    Pannu S; Rosmarin D
    Am J Clin Dermatol; 2021 May; 22(3):293-300. PubMed ID: 33586126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study.
    Botelho KP; Pontes MAA; Rodrigues CEM; Freitas MVC
    Metab Syndr Relat Disord; 2020 Apr; 18(3):154-160. PubMed ID: 31928509
    [No Abstract]   [Full Text] [Related]  

  • 14. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing cardiometabolic risk profile in patients with psoriasis.
    Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
    Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study.
    Jiang B; Zheng Y; Chen Y; Chen Y; Li Q; Zhu C; Wang N; Han B; Zhai H; Lin D; Lu Y
    Lipids Health Dis; 2018 Apr; 17(1):92. PubMed ID: 29678174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
    Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome and individual criterion in US adolescents: 2001-2010 National Health and Nutrition Examination Survey.
    Miller JM; Kaylor MB; Johannsson M; Bay C; Churilla JR
    Metab Syndr Relat Disord; 2014 Dec; 12(10):527-32. PubMed ID: 25247821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.
    Goharian TS; Goetze JP; Faber J; Andersen LB; Grøntved A; Jeppesen JL
    Am J Hypertens; 2017 Jun; 30(6):561-568. PubMed ID: 28338810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the metabolic syndrome in children with psoriatic disease.
    Goldminz AM; Buzney CD; Kim N; Au SC; Levine DE; Wang AC; Volf EM; Yaniv SS; Kerensky TA; Bhandarkar M; Dumont NM; Lizzul PF; Loo DS; Kulig JW; Brown ME; Lopez-Benitez JM; Miller LC; Gottlieb AB
    Pediatr Dermatol; 2013; 30(6):700-5. PubMed ID: 24016334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.